{"id":2589,"date":"2024-01-09T16:42:14","date_gmt":"2024-01-09T13:42:14","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=2589"},"modified":"2024-01-09T17:16:22","modified_gmt":"2024-01-09T14:16:22","slug":"turk-ilac-sektorunun-yukselen-yildizi-humanis-hizla-buyumeye-devam-ediyor","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=2589","title":{"rendered":"T\u00fcrk \u0130la\u00e7 Sekt\u00f6r\u00fcn\u00fcn Y\u00fckselen Y\u0131ld\u0131z\u0131 Humanis, H\u0131zla B\u00fcy\u00fcmeye Devam Ediyor"},"content":{"rendered":"\n<p>Bug\u00fcn 3 k\u0131tada 25\u2019ten fazla \u00fclkeye \u00fcr\u00fcnlerini ula\u015ft\u0131ran, 2023 y\u0131l\u0131nda T\u00fcrkiye\u2019den \u00c7in\u2019e ila\u00e7 ihracat\u0131 yapan ilk T\u00fcrk ila\u00e7 firmas\u0131 olarak T\u00fcrkiye\u2019nin en h\u0131zl\u0131 b\u00fcy\u00fcyen ila\u00e7 \u015firketleri aras\u0131nda yer alan Humanis\u2019in Teknik Operasyonlar Genel M\u00fcd\u00fcr\u00fc Fatih Elay ile yerli ila\u00e7 \u00fcretiminin \u00f6neminden Humanis\u2019in Ar-Ge yat\u0131r\u0131mlar\u0131 ve geli\u015ftirdi\u011fi yeni \u00fcr\u00fcnlere, \u00fcretim s\u00fcre\u00e7lerinden ihracat hedeflerine kadar geni\u015f yelpazade bir s\u00f6yle\u015fi ger\u00e7ekle\u015ftirdik.<\/p>\n\n\n\n<p><strong>Fatih Elay<\/strong><\/p>\n\n\n\n<p><strong>Humanis Teknik Operasyonlar Genel M\u00fcd\u00fcr\u00fc<\/strong><\/p>\n\n\n\n<p><strong>Sizi biraz tan\u0131yabilir miyiz?<\/strong><\/p>\n\n\n\n<p>Kimya e\u011fitimi ald\u0131ktan sonra ila\u00e7 sekt\u00f6r\u00fcne giri\u015f yapt\u0131m ve bu alanda da 20 y\u0131l\u0131 a\u015fk\u0131n bir deneyimim var. \u015eimdiye kadar sekt\u00f6r\u00fcm\u00fcz\u00fcn \u00fcretim alan\u0131n\u0131n farkl\u0131 a\u015famalar\u0131nda g\u00f6revlerde bulundum. 2011 y\u0131l\u0131nda \u00fcretim tesisinin kurulumundan ve y\u00f6netiminden sorumlu olarak Humanis\u2019e (o d\u00f6nem Pharmactive ad\u0131yla faaliyet g\u00f6steren) kat\u0131ld\u0131m. \u015eu anda teknik operasyonlar genel m\u00fcd\u00fcrl\u00fc\u011f\u00fc g\u00f6revini y\u00fcr\u00fctmekteyim.<\/p>\n\n\n\n<p><strong>Humanis\u2019in \u00fcretim tesisini bize biraz anlat\u0131r m\u0131s\u0131n\u0131z?<\/strong><\/p>\n\n\n\n<p>\u00dcretim tesisimiz, Tekirda\u011f \u00c7erkezk\u00f6y\u2019de 108.000 m<sup>2<\/sup>\u2019lik bir alana kurulu olup, y\u0131lda 330 milyon kutuluk \u00fcretim kapasitesine sahiptir. Yak\u0131n zamanda \u00fcretim tesisimizde yapaca\u011f\u0131m\u0131z ilave yat\u0131r\u0131mlar ile bu kapasiteyi 450 milyon kutunun \u00fczerine \u00e7\u0131karmay\u0131 planl\u0131yoruz.<\/p>\n\n\n\n<p>Kat\u0131, yar\u0131 kat\u0131 ve s\u0131v\u0131 formlar olarak adland\u0131r\u0131lan ve betalaktam i\u00e7ermeyen ila\u00e7 t\u00fcrlerini \u00fcretebilen, \u00fcst d\u00fczey teknoloji imk\u00e2nlar\u0131na sahip bu tesisimizde bir\u00e7ok farkl\u0131 tedavi alanlar\u0131na hizmet eden ila\u00e7lar \u00fcretmekteyiz. \u0130lerleyen d\u00f6nemlerde onkoloji, hormon, steril \u00fcr\u00fcn gruplar\u0131 gibi ba\u015fka tedavi alanlar\u0131na y\u00f6nelik \u00fcretim yapmay\u0131 hedefliyoruz.<\/p>\n\n\n\n<p><strong>\u00dcr\u00fcn portf\u00f6y\u00fcn\u00fcz\u00fc anlat\u0131r m\u0131s\u0131n\u0131z? Hangi tedavi alanlar\u0131na yo\u011funla\u015fm\u0131\u015f durumdas\u0131n\u0131z, \u015fu an ruhsatl\u0131 ka\u00e7 \u00fcr\u00fcn\u00fcn\u00fcz bulunuyor? Yak\u0131n gelecekte pazara sunmay\u0131 planlad\u0131\u011f\u0131n\u0131z \u00fcr\u00fcnleriniz var m\u0131?<\/strong><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignleft size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSCF3601-1024x683.jpg\" alt=\"\" class=\"wp-image-2593\" style=\"width:258px;height:172px\" width=\"258\" height=\"172\" srcset=\"https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSCF3601-1024x683.jpg 1024w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSCF3601-300x200.jpg 300w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSCF3601-768x512.jpg 768w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSCF3601-1536x1024.jpg 1536w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSCF3601-2048x1365.jpg 2048w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSCF3601-310x205.jpg 310w\" sizes=\"(max-width: 258px) 100vw, 258px\" \/><\/figure><\/div>\n\n\n<p>Bir\u00e7ok \u00f6nemli alanda etkin ve \u00f6nc\u00fc \u00e7\u00f6z\u00fcmler sunan bir \u00fcr\u00fcn portf\u00f6y\u00fcm\u00fcz var. Bu alanlar\u0131 pediatri, kardiyoloji, g\u00f6\u011f\u00fcs hastal\u0131klar\u0131, kulak-bo\u011faz-burun, dahiliye, enfeksiyon, gastroenteroloji, dermatoloji, fizik tedavi ve rehabilitasyon, ortopedi ve acil t\u0131p olarak s\u0131ralayabilirim. Bu y\u0131l nadir hastal\u0131klar alan\u0131nda da ilk ad\u0131m\u0131m\u0131z\u0131 att\u0131k ve serebrotendinoz ksantomatozis hastal\u0131\u011f\u0131n\u0131n tedavisi i\u00e7in \u00fcretti\u011fimiz ilac\u0131m\u0131z\u0131 kullan\u0131ma sunduk. Bu, bizim i\u00e7in \u00f6nemli bir ad\u0131m. \u0130nsan odakl\u0131 bir firma olarak zorlu bir alan olan nadir hastal\u0131klar i\u00e7in \u00e7\u00f6z\u00fcm \u00fcretmek bizim i\u00e7in \u00e7ok k\u0131ymetli. Bu \u00fcr\u00fcn\u00fcm\u00fczle Alt\u0131n Havan \u00d6d\u00fclleri\u2019nde \u2018\u00dcr\u00fcn \u00d6d\u00fcl\u00fc\u2019ne l\u00e2y\u0131k g\u00f6r\u00fcld\u00fc\u011f\u00fcm\u00fcz i\u00e7in de \u00e7ok mutluyuz. Bu alanda \u00e7al\u0131\u015fmalar\u0131m\u0131z\u0131 b\u00fcy\u00fctmeye devam edece\u011fiz tabii ki. 2030 y\u0131l\u0131na kadar da nadir hastal\u0131klar, merkezi sinir sistemi hastal\u0131klar\u0131, diyabet, kardiyoloji ve onkoloji gibi alanlarda yerimizi alaca\u011f\u0131z. Bug\u00fcn 200\u2019den fazla ruhsatl\u0131 \u00fcr\u00fcn\u00fc olan bir firma olarak sa\u011fl\u0131\u011fa bir b\u00fct\u00fcn olarak bakt\u0131\u011f\u0131m\u0131z\u0131 da eklemek isterim. Bu nedenle 2023 y\u0131l\u0131nda t\u00fcketici sa\u011fl\u0131\u011f\u0131 pazar\u0131na da sa\u00e7 sa\u011fl\u0131\u011f\u0131 ve mide sa\u011fl\u0131\u011f\u0131 alan\u0131ndaki \u00fcr\u00fcnlerimiz ile giri\u015f yapt\u0131k. \u00c7ok yak\u0131n zamanda ise vitaminler ve anne-bebek sa\u011fl\u0131\u011f\u0131 alanlar\u0131nda da yeni markalar\u0131m\u0131z\u0131 t\u00fcketici ile bulu\u015fmaya devam edece\u011fiz.<\/p>\n\n\n\n<p><strong>\u00dcretim deste\u011fi sundu\u011funuz global firmalar var m\u0131?<\/strong><\/p>\n\n\n\n<p>Evet, tabii ki. \u00dcretim hizmeti alma ihtiyac\u0131 duyan ve bir\u00e7o\u011fu global olan firmalar y\u00fcksek kalite standartlar\u0131na ve yenilik\u00e7i teknolojiye sahip tesisimizi tercih ediyor ve bizlere ula\u015f\u0131yor. Bu \u00e7er\u00e7evede \u00fclkemizde at\u0131lan yerelle\u015fme ad\u0131mlar\u0131na da Humanis olarak \u00e7ok katk\u0131 sa\u011flad\u0131k. Bundan dolay\u0131 da ayr\u0131ca gurur duyuyoruz.<\/p>\n\n\n\n<p>Humanis olarak 2015 y\u0131l\u0131ndan beri Avrupa Birli\u011fi \u00fclkelerinde ge\u00e7erli olan EU GMP (\u0130yi \u00dcretim Uygulamalar\u0131) sertifikas\u0131na sahibiz. Yak\u0131n zamanda da Rusya ve Kanada\u2019dan GMP sertifikas\u0131 almaya hak kazanm\u0131\u015f bir firma olarak bir\u00e7ok b\u00f6lgeye ve farkl\u0131 pazarlara y\u00f6nelik \u00fcretim yapabilen bir konumda oldu\u011fumuzu kan\u0131tlam\u0131\u015f olduk. Dolay\u0131s\u0131yla bir\u00e7ok global firman\u0131n \u00fcretim ortakl\u0131\u011f\u0131 noktas\u0131nda tercih etti\u011fi bir firmay\u0131z.<\/p>\n\n\n\n<p><strong>\u00dcretim s\u00fcrecinde do\u011fay\u0131 korumak ad\u0131na ne gibi \u00f6nlemler al\u0131yorsunuz?<\/strong><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignleft size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSCF4312-1024x683.jpg\" alt=\"\" class=\"wp-image-2591\" style=\"width:260px;height:174px\" width=\"260\" height=\"174\" srcset=\"https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSCF4312-1024x683.jpg 1024w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSCF4312-300x200.jpg 300w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSCF4312-768x512.jpg 768w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSCF4312-1536x1024.jpg 1536w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSCF4312-2048x1365.jpg 2048w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSCF4312-110x75.jpg 110w\" sizes=\"(max-width: 260px) 100vw, 260px\" \/><\/figure><\/div>\n\n\n<p>Biz \u2018insan\u2019 odakl\u0131 sa\u011fl\u0131k felsefesini benimseyen bir ila\u00e7 firmas\u0131y\u0131z. Hatta 2023 y\u0131l\u0131 itibar\u0131yla bu \u00f6zelli\u011fimizi marka ad\u0131m\u0131zda da ta\u015f\u0131mak i\u00e7in ad\u0131m\u0131z\u0131, i\u00e7inde insan sevgisini bar\u0131nd\u0131ran Humanis olarak de\u011fi\u015ftirdik. Marka d\u00f6n\u00fc\u015f\u00fcm\u00fc kapsam\u0131nda Humanis ad\u0131 alt\u0131nda yolculu\u011fumuza devam diyoruz. \u0130nsan odakl\u0131l\u0131\u011f\u0131m\u0131z ve etkin sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleri \u00fcretme tutkumuz \u00e7evre hassasiyetimizle birlikte b\u00fcy\u00fcyor tabii ki. Bu nedenle T\u00fcrkiye ila\u00e7 sekt\u00f6r\u00fcn\u00fcn h\u0131zla b\u00fcy\u00fcyen bir ila\u00e7 firmas\u0131 olarak enerji kullan\u0131m\u0131, at\u0131k y\u00f6netimi gibi konularda her zaman \u00f6zenli olduk. Fabrika alan\u0131m\u0131z\u0131n geni\u015fli\u011fi g\u00fcne\u015f panelleri kullanmak a\u00e7\u0131s\u0131ndan olduk\u00e7a avantaj sa\u011fl\u0131yor. Ye\u015fil enerji kullan\u0131m\u0131m\u0131z\u0131 planlamak i\u00e7in GES (G\u00fcne\u015f Enerji Sistemi) projesi ba\u015flatt\u0131k. 2022 y\u0131l\u0131nda GES projesini ger\u00e7ekle\u015ftiren ilk yerli ila\u00e7 firmas\u0131 olarak sekt\u00f6r\u00fcm\u00fcze bu alanda \u00f6nc\u00fcl\u00fck ettik. Bu proje kapsam\u0131nda, g\u00fcne\u015f paneli say\u0131m\u0131z\u0131 2024 y\u0131l\u0131nda tam 16.000 adede \u00e7\u0131karm\u0131\u015f olaca\u011f\u0131z. Bu sayede de ye\u015fil enerji kullan\u0131m kapasitemiz y\u00fczde 100\u2019e \u00e7\u0131kacak ve y\u0131lda 3.000 konutun 1 y\u0131ll\u0131k elektrik t\u00fcketimine denk gelen 3.800 ton karbon sal\u0131n\u0131m\u0131n\u0131 engellemi\u015f olaca\u011f\u0131z. At\u0131k geri d\u00f6n\u00fc\u015f\u00fcm projelerimiz ile de 1 y\u0131ll\u0131k s\u00fcrede 360 ton k\u00e2\u011f\u0131t tasarrufu sa\u011flayarak, yakla\u015f\u0131k 6.000 yeti\u015fkin a\u011fac\u0131n kesilmesini engelledik.<\/p>\n\n\n\n<p>Yenilenebilir enerji kaynaklar\u0131n\u0131n yan\u0131nda yenilenebilir \u0131s\u0131 kaynaklar\u0131 i\u00e7in de projeler geli\u015ftiriyoruz; bu kapsamda \u0131s\u0131 pompas\u0131 projemizi yak\u0131n zamanda devreye alaca\u011f\u0131z. Proje tamamland\u0131ktan sonra, y\u0131lda 500 konutun 1 y\u0131ll\u0131k \u0131s\u0131nma t\u00fcketimine denk gelen 600 ton karbon sal\u0131m\u0131 engellenmi\u015f olaca\u011f\u0131z.<\/p>\n\n\n\n<p>Kuruldu\u011fumuzdan beri dijitalle\u015fme konusunda da ciddi projeler ger\u00e7ekle\u015ftiriyoruz. Bu konudaki geli\u015fmeleri takip ederek yeni projeler geli\u015ftiriyor ve k\u00e2\u011f\u0131t kullan\u0131m\u0131n\u0131 azaltmak konusunda \u00f6nlemler almaya devam ediyoruz.<\/p>\n\n\n\n<p><strong>Yerli ila\u00e7 \u00fcretiminin bir \u00fclke i\u00e7in \u00f6nemi ve T\u00fcrkiye ekonomisi i\u00e7in Humanis\u2019in&nbsp;katk\u0131s\u0131n\u0131 de\u011ferlendirecek olursan\u0131z neler s\u00f6ylersiniz?<\/strong><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignleft size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/Cerkezkoy_Fabrika-1024x573.jpg\" alt=\"\" class=\"wp-image-2592\" style=\"width:262px;height:147px\" width=\"262\" height=\"147\" srcset=\"https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/Cerkezkoy_Fabrika-1024x573.jpg 1024w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/Cerkezkoy_Fabrika-300x168.jpg 300w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/Cerkezkoy_Fabrika-768x430.jpg 768w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/Cerkezkoy_Fabrika-1536x860.jpg 1536w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/Cerkezkoy_Fabrika.jpg 1920w\" sizes=\"(max-width: 262px) 100vw, 262px\" \/><\/figure><\/div>\n\n\n<p>\u0130la\u00e7 sekt\u00f6r\u00fcn\u00fcn pazar pay\u0131n\u0131 d\u00fc\u015f\u00fcnd\u00fc\u011f\u00fcm\u00fczde yerli ila\u00e7 \u00fcretimi bir \u00fclkenin kalk\u0131nmas\u0131nda \u00e7ok \u00f6nemli bir g\u00f6rev \u00fcstleniyor. Bu konuda \u00fclkemizde \u00f6nemli ad\u0131mlar at\u0131ld\u0131. T\u00fcrkiye, art\u0131k global \u00f6l\u00e7ekte ve y\u00fcksek kalitede \u00fcretim yapabilecek bir ila\u00e7 end\u00fcstrisine sahip. 2022 y\u0131l\u0131 verilerine g\u00f6re \u00fclkemizde faaliyet g\u00f6steren 855 kurulu\u015f ve 103 ila\u00e7 ve hammadde \u00fcretim tesisi bulunuyor. Yine ge\u00e7ti\u011fimiz y\u0131l\u0131n verilerine g\u00f6re 1,5 trilyon dolara ula\u015fan d\u00fcnya ila\u00e7 pazar\u0131nda, \u00fclke olarak 21. s\u0131rada yer ald\u0131k. D\u00fcnyan\u0131n en b\u00fcy\u00fck pazarlar\u0131ndan birinde g\u00fc\u00e7l\u00fc teknolojik altyap\u0131m\u0131z ve istihdam kayna\u011f\u0131m\u0131z sayesinde gelecekte daha g\u00fc\u00e7l\u00fc bir noktaya gelece\u011fimize inan\u0131yorum. Yerli ila\u00e7 \u00fcretimine verilen \u00f6nem sayesinde T\u00fcrkiye ekonomisinin g\u00fc\u00e7lenmesi i\u00e7in biz de Humanis olarak katk\u0131 sa\u011flamaya devam edece\u011fiz. Yeni yat\u0131r\u0131mlar\u0131m\u0131z, global pazarda her ge\u00e7en y\u0131l artan pay\u0131m\u0131z ve gelece\u011fe y\u00f6n veren \u00e7al\u0131\u015fmalar\u0131m\u0131zla \u00fclkemize hizmet vermekten mutluluk duyuyoruz.<\/p>\n\n\n\n<p>\u0130la\u00e7ta d\u0131\u015fa ba\u011f\u0131ml\u0131l\u0131\u011f\u0131n azalmas\u0131 da \u00fclkeler i\u00e7in stratejik \u00f6nem arz etmektedir. \u0130la\u00e7 end\u00fcstrisinde belli bir g\u00fcce ula\u015fm\u0131\u015f \u00fclkeler bu stratejinin s\u00fcrd\u00fcr\u00fclmesinde \u00f6nemli rol oynamakta, \u015firketlerin Ar-Ge faaliyetleri ve kabiliyetleri her ge\u00e7en g\u00fcn daha \u00e7ok \u00f6nem arz etmektedir. Biz de Humanis olarak bu konuda \u00fclkemize \u00f6nemli bir katk\u0131 sa\u011flad\u0131\u011f\u0131m\u0131za inan\u0131yoruz. Ayr\u0131ca \u00fcretim tesisimizin sahip oldu\u011fu olanaklar sayesinde \u00fcretim hizmetlerinde de olduk\u00e7a \u00f6nemli bir konumday\u0131z. Geli\u015fmi\u015f teknolojik donan\u0131m ile y\u00fcksek kalite standartlar\u0131nda \u00fcretim yapabildi\u011fimiz i\u00e7in global firmalara \u00fcretim partnerli\u011fi yap\u0131yor ve ithal bir\u00e7ok ilac\u0131 art\u0131k biz \u00fcretebiliyoruz.<\/p>\n\n\n\n<p><strong>Humanis \u015fu anda hangi \u00fclkelere \u00fcr\u00fcn ihracat\u0131 yap\u0131yor?<\/strong><\/p>\n\n\n\n<p>Bug\u00fcn 3 k\u0131tada ihracat yapan bir firmay\u0131z. Almanya, \u0130svi\u00e7re, Fransa, \u0130ngiltere, \u0130spanya, \u0130talya gibi Avrupa\u2019n\u0131n en g\u00fc\u00e7l\u00fc \u00fclkelerine ihracat yap\u0131yoruz. Ayr\u0131ca Azerbaycan, G\u00fcrcistan, Etiyopya, Afganistan, Irak ba\u015fta olmak \u00fczere d\u00fcnya \u00e7ap\u0131nda 25\u2019ten fazla \u00fclkeye \u00fcr\u00fcnlerimizi ula\u015ft\u0131r\u0131yoruz. 2023 y\u0131l\u0131nda \u00fclkemiz ad\u0131na da \u00f6nemli bir ad\u0131m atarak T\u00fcrkiye\u2019den \u00c7in\u2019e ila\u00e7 ihracat\u0131 yapan ilk firma olduk.<\/p>\n\n\n\n<p><strong>\u00d6n\u00fcm\u00fczdeki y\u0131llar i\u00e7in \u00f6ncelikli olarak hangi pazarlar\u0131 hedefliyorsunuz?<\/strong><\/p>\n\n\n\n<p>Cesur ve \u00f6nc\u00fc ad\u0131mlar atmak pazarlama stratejilerimizin \u00f6nemli iki \u00f6zelli\u011fi. Bu nedenle hedeflerimiz de b\u00fcy\u00fck elbette. 2030 y\u0131l\u0131na kadar ABD pazar\u0131na giri\u015f yapmay\u0131 planl\u0131yoruz. Ayr\u0131ca yine bu y\u0131l Almanya\u2019da \u015firket a\u00e7arak Avrupa\u2019daki konumumuzu g\u00fc\u00e7lendirmeye ba\u015flad\u0131k. K\u00f6rfez \u00fclkelerinde b\u00fcy\u00fcmek konusunda da yat\u0131r\u0131m planlar\u0131m\u0131z oldu\u011funu belirtmeliyim.<\/p>\n\n\n\n<p><strong>Humanis\u2019in Ar-Ge\u2019ye verdi\u011fi \u00f6nem ve bu alandaki \u00e7al\u0131\u015fmalar\u0131ndan s\u00f6z eder misiniz, y\u0131lda Ar-Ge\u2019ye ne kadar pay ay\u0131r\u0131yorsunuz? Ar-Ge merkeziniz ve Ar-Ge ekibiniz hakk\u0131nda biraz bilgi verir misiniz?<\/strong><\/p>\n\n\n\n<p>Sanayi ve Teknoloji Bakanl\u0131\u011f\u0131 taraf\u0131ndan te\u015fvik edilen, \u00fclkemizin en b\u00fcy\u00fck 5 ila\u00e7 Ar-Ge merkezinden birine sahibiz. Ar-Ge ekibimizdeki alan\u0131nda uzman yakla\u015f\u0131k 100 bilim insan\u0131 ile birlikte, \u015fimdiye kadar 100\u2019den fazla molek\u00fclde e\u015fde\u011fer \u00fcr\u00fcn geli\u015ftirdik ve 20\u2019den fazla \u00fcr\u00fcn i\u00e7in de patent ba\u015fvurular\u0131 yapt\u0131k. QbD, EMA ve ICH reg\u00fclasyonlar\u0131na uyumlu olan Ar-Ge merkezimize y\u0131ll\u0131k ciromuzun yakla\u015f\u0131k %10\u2019unu aktar\u0131yor ve insanl\u0131\u011fa hizmet edecek etkin ve g\u00fcvenilir \u00e7\u00f6z\u00fcmler \u00fcretmek i\u00e7in \u00e7al\u0131\u015fmalar\u0131m\u0131z\u0131 s\u00fcrd\u00fcr\u00fcyoruz. Nadir hastal\u0131klar ve PAH tedavisine y\u00f6nelik \u00fcr\u00fcn geli\u015ftirme \u00e7al\u0131\u015fmalar\u0131m\u0131z s\u00fcrerken, uyuz hastal\u0131\u011f\u0131 tedavisinde kullan\u0131lan \u2018ivermektin\u2019 etken maddeli ilac\u0131 yerli \u00fcretip, \u00fclkemiz pazar\u0131na sunan ilk ve tek ila\u00e7 firmas\u0131y\u0131z. \u00dclkemizde son zamanlarda art\u0131\u015f g\u00f6r\u00fclen uyuz vakalar\u0131na y\u00f6nelik ivermektin tedavisini sunarak \u00f6nemli bir ihtiyac\u0131 kar\u015f\u0131lam\u0131\u015f olduk.<\/p>\n\n\n\n<p><strong>Cumhuriyetimizin 100. y\u0131l\u0131na \u00f6zel bir k\u0131sa film yay\u0131mlad\u0131n\u0131z. Bu filmi k\u0131saca anlat\u0131r m\u0131s\u0131n\u0131z?<\/strong><\/p>\n\n\n\n<p>Bize emanet edilmi\u015f en k\u0131ymetli de\u011ferlerden biri olan Cumhuriyetimizin 100. ya\u015f\u0131n\u0131 kutlamak gibi tarihi anlamda \u00f6zel g\u00fcne \u015fahit olduk. Bilimin \u0131\u015f\u0131\u011f\u0131nda \u00fcreten, teknolojinin \u00e7ok katmanl\u0131 geli\u015fimiyle birlikte b\u00fcy\u00fcyen, kapsaml\u0131 bir e\u011fitimle de birikimini gelece\u011fe ta\u015f\u0131yan bir sekt\u00f6rde hizmet veriyoruz. Cumhuriyetimizin bu sayd\u0131\u011f\u0131m alanlar\u0131n geli\u015fmesine olan katk\u0131s\u0131 ve de\u011feri paha bi\u00e7ilemez. Bug\u00fcn global oyuncularla yar\u0131\u015fabilecek kalitede \u00fcretim yapabilmemizin sebebi de Cumhuriyetin bize kazand\u0131rd\u0131klar\u0131. Ulu \u00d6nder Mustafa Kemal Atat\u00fcrk\u2019\u00fcn bize emanet etti\u011fi Cumhuriyetimize verdi\u011fimiz bu \u00f6nemi de \u00f6zel bir k\u0131sa filmle vurgulamak istedik. Rotam\u0131z Cumhuriyet ad\u0131n\u0131 ta\u015f\u0131yan filmimizin, bu y\u0131l\u0131n \u00f6zel kutlamalar\u0131na anlaml\u0131 bir iz b\u0131rakaca\u011f\u0131n\u0131 umuyoruz.<\/p>\n\n\n\n<p><strong>Sanat\u0131 destekleyen bir firmas\u0131n\u0131z. Bu konuya neden \u00f6nem veriyorsunuz? En son hangi projeleri ger\u00e7ekle\u015ftirdiniz?<\/strong><\/p>\n\n\n\n<p>K\u00fclt\u00fcr sanat projelerinde etkin rol oynamak bizim i\u00e7in \u00e7ok de\u011ferli. Sanat\u0131n iyile\u015ftirici g\u00fcc\u00fcne inanan bir ila\u00e7 firmas\u0131 olarak \u00e7ok de\u011ferli T\u00fcrk ressam\u0131m\u0131z \u015eevket Da\u011f\u2019\u0131n bir\u00e7ok eserini ilk kez bir araya getiren bir sergiye imza att\u0131k. Organizasyonunu \u00fcstlendi\u011fimiz \u2018Zaman ve Mek\u00e2n\u0131n B\u00fcy\u00fcs\u00fcnde Bir Ressam: \u015eevket Da\u011f\u2019 sergisi Ankara ve \u0130stanbul\u2019un \u00f6nemli sanat merkezlerinde binlerce ki\u015fiye ula\u015ft\u0131. Bunun gibi projeler geli\u015ftirmeye ve sanat\u0131n etkili g\u00fcc\u00fcn\u00fc insanlarla bulu\u015fturmaya devam edece\u011fiz.<\/p>\n\n\n\n<p><strong>Humanis, insan kaynaklar\u0131 alan\u0131nda da \u00f6nemli \u00f6d\u00fcller ald\u0131. Bunlar\u0131 k\u0131saca aktar\u0131r m\u0131s\u0131n\u0131z?<\/strong><\/p>\n\n\n\n<p>\u00dcretim motivasyonumuzdaki insan odakl\u0131 yakla\u015f\u0131m, \u00e7al\u0131\u015fma modellerimizde de kendini g\u00f6steriyor. Etkili sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleri \u00fcretme tutkumuzu payla\u015ft\u0131\u011f\u0131m\u0131z b\u00fcy\u00fck bir ekibimiz var. Fabrikada, merkez ofiste ve sahada 1.200\u2019den fazla ki\u015fiden olu\u015fan kadromuzun her biriminde, insan odakl\u0131 anlay\u0131\u015f\u0131m\u0131z\u0131 muhafaza ederek \u00e7al\u0131\u015f\u0131yoruz. Bu yakla\u015f\u0131m\u0131m\u0131z nedeniyle iki y\u0131l \u00fcst \u00fcste Great Place to Work taraf\u0131ndan \u2018Harika \u0130\u015f Yeri Sertifikas\u0131\u2019 ve Kariyer.net taraf\u0131ndan da \u2018\u0130nsana Sayg\u0131 \u00d6d\u00fcl\u00fc\u2019ne l\u00e2y\u0131k g\u00f6r\u00fcld\u00fck.<\/p>\n\n\n\n<p><strong>Son olarak, Humanis\u2019in gelecek hedeflerinde neler var?<\/strong><\/p>\n\n\n\n<p>Humanis olarak iyi ve sa\u011fl\u0131kl\u0131 ya\u015fam\u0131 destekleme misyonumuzu ger\u00e7ekle\u015ftirmek ad\u0131na, \u015firket ve \u00fcr\u00fcn portf\u00f6y\u00fc sat\u0131n al\u0131mlar\u0131 konusunda yurt i\u00e7i ve yurt d\u0131\u015f\u0131 aray\u0131\u015flar\u0131m\u0131z s\u00fcr\u00fcyor. B\u00fct\u00fcn faaliyet alanlar\u0131m\u0131zda sekt\u00f6r\u00fcm\u00fcz\u00fcn geli\u015fimine katk\u0131da bulunmak i\u00e7in b\u00fcy\u00fck bir \u00f6zveri ve tutkuyla \u00e7al\u0131\u015f\u0131rken, bug\u00fcn geldi\u011fimiz noktada T\u00fcrkiye\u2019nin en h\u0131zl\u0131 b\u00fcy\u00fcyen ila\u00e7 \u015firketlerinden biriyiz. Hedeflerimiz do\u011frultusunda ekibimizi, \u00fcr\u00fcn portf\u00f6y\u00fcm\u00fcz\u00fc ve etki alan\u0131m\u0131z\u0131 geni\u015fleterek, daha iyiye do\u011fru geli\u015fmeye ve b\u00fcy\u00fcmeye devam edece\u011fiz.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bug\u00fcn 3 k\u0131tada 25\u2019ten fazla \u00fclkeye \u00fcr\u00fcnlerini ula\u015ft\u0131ran, 2023 y\u0131l\u0131nda T\u00fcrkiye\u2019den \u00c7in\u2019e ila\u00e7 ihracat\u0131 yapan ilk T\u00fcrk ila\u00e7 firmas\u0131 olarak T\u00fcrkiye\u2019nin en h\u0131zl\u0131 b\u00fcy\u00fcyen ila\u00e7 \u015firketleri aras\u0131nda yer alan Humanis\u2019in Teknik Operasyonlar Genel M\u00fcd\u00fcr\u00fc Fatih Elay ile yerli ila\u00e7 \u00fcretiminin \u00f6neminden Humanis\u2019in Ar-Ge yat\u0131r\u0131mlar\u0131 ve geli\u015ftirdi\u011fi yeni \u00fcr\u00fcnlere, \u00fcretim s\u00fcre\u00e7lerinden ihracat hedeflerine kadar geni\u015f yelpazade bir s\u00f6yle\u015fi ger\u00e7ekle\u015ftirdik.<\/p>\n","protected":false},"author":1,"featured_media":2595,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/2589"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2589"}],"version-history":[{"count":2,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/2589\/revisions"}],"predecessor-version":[{"id":2596,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/2589\/revisions\/2596"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/2595"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2589"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2589"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2589"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}